tetraethylammonium has been researched along with fluorobenzenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castillo-Henkel, C; Castillo-Henkel, E; López-Canales, JS; López-Sanchez, P; Perez-Alvarez, VM; Polanco, AC; Wens-Flores, I | 1 |
| Konidaris, KF; Metrangolo, P; Meyer, F; Pilati, T; Resnati, G | 1 |
2 other study(ies) available for tetraethylammonium and fluorobenzenes
| Article | Year |
|---|---|
The methyl ester of rosuvastatin elicited an endothelium-independent and 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent relaxant effect in rat aorta.
Topics: Animals; Aorta; Cycloheximide; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl CoA Reductases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Tetraethylammonium; Vasodilation; Vasodilator Agents | 2011 |
Connectivity and Topology Invariance in Self-Assembled and Halogen-Bonded Anionic (6,3)-Networks.
Topics: Crystallization; Fluorobenzenes; Hydrogen Bonding; Iodobenzenes; Organophosphorus Compounds; Tetraethylammonium | 2017 |